Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Journal of Hematology|February 12, 2025
Low Rate of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Despite Limited Use of Intrathecal ProphylaxisAamer Aleem, Farjah Algahtani, Musa Alzahrani, et al.
Saudi Journal of Medicine & Medical Sciences|March 14, 2022
Survival and Epidemiologic Trends of Lymphomas in Saudi Arabia: A 10-Year Report from a Tertiary Care HospitalMashael Yahya Altowairqi, Mohammed Yousef Alyousef, Mohammed Khaled Ghandour, et al.
Biomed Research International|August 1, 2022
Knowledge and Behavior toward Venous Thromboembolism Event Prophylaxis and Treatment Protocols among Medical Interns in RiyadhZohair Al Aseri, Jumanah Meshari Muammar, Najd Fahad Aldakkan, et al.
Journal of Pediatric Hematology/Oncology|February 11, 2012
Sickle cell disease subphenotypes in patients from Southwestern Province of Saudi ArabiaAbdulrahman Alsultan, Aamer Aleem, Hazem Ghabbour, et al.
Frontiers in Medicine|June 4, 2026
Genotype-phenotype correlation in alpha-thalassemia: predicting genetic subgroups via laboratory parametersMusa Fares Alzahrani, Saud Alrsheed, Homoud Al Gadheb, et al.
Saudi Journal of Medicine & Medical Sciences|February 12, 2025
Outcomes of Patients with Hematological Malignancies Admitted to the Intensive Care Unit at a Tertiary Care Center in Saudi ArabiaGhazi Saud Alotaibi, Yazeed Alekrish, Fares Aldokhayel, et al.
Journal of Cancer|December 7, 2018
Detection of Exon 12 and 14 Mutations in Janus Kinase 2 Gene Including a Novel Mutant in V617F Negative Polycythemia Vera Patients from PakistanAfia Muhammad Akram, Humera Kausar, Asma Chaudhary, et al.
Cancer Biology & Therapy|March 10, 2017
Presence of novel compound BCR-ABL mutations in late chronic and advanced phase imatinib sensitive CML patients indicates their possible role in CML progressionAfia Muhammad Akram, Zafar Iqbal, Tanveer Akhtar, et al.
Future Science OA|January 6, 2026
"Does the dose of hydroxyurea correlate with shorter hospital stay and higher fetal hemoglobin levels in patients with sickle cell disease?"Musa Fares Alzahrani, Abdulaziz Albacker, Abdulmajeed Alshabanat, et al.
World Journal of Clinical Oncology|December 8, 2025
Omics and artificial intelligence integration for stratifying blast crisis CML using COSMIC signatures and pan-cancer precision drug repurposingAbdulkareem AlGarni, Nawaf Alanazi, Sarah AlMukhaylid, et al.
Pageof 6